The two clinical variables, i.e. HbA1c values and insulin treatment were the only significant predictors of increased perceived hyper- and hypoglycaemia, with the regression models explaining 23.2% and 26.8% of the variance respectively. The gene discussed is INS; the disease is Hypoglycemia.